Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases

Clinical trials testing the safety and efficacy of immunosuppressive agents for the treatment of autoimmune diseases should also be designed to evaluate immunocompetency. The most clinically relevant outcome for assessing immunocompetency is the infection rate. Therefore, a systematic approach to sc...

Description complète

Détails bibliographiques

Publié dans:	Clinical immunology (Orlando, Fla.). - 1999. - 123(2007), 3 vom: 07. Juni, Seite 235-43
Auteur principal:	Looney, R John (Auteur)
Autres auteurs:	Diamond, Betty, Holers, V Michael, Levesque, Marc C, Moreland, Larry, Nahm, Moon H, St Clair, E William, Autoimmunity Centers of Excellence Immunocompetency Committee
Format:	Article
Langue:	English
Publié:	2007
Accès à la collection:	Clinical immunology (Orlando, Fla.)
Sujets:	Journal Article Practice Guideline Review Immunosuppressive Agents